Outset Medical Inc (OM) - Total Liabilities
Based on the latest financial reports, Outset Medical Inc (OM) has total liabilities worth $137.77 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Outset Medical Inc - Total Liabilities Trend (2018–2025)
This chart illustrates how Outset Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See OM working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Outset Medical Inc Competitors by Total Liabilities
The table below lists competitors of Outset Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Panache Digilife Limited
NSE:PANACHE
|
India | Rs590.05 Million |
|
Tsann Kuen Enterprise Co Ltd
TW:2430
|
Taiwan | NT$9.09 Billion |
|
JHM Consolidation Bhd
KLSE:0127
|
Malaysia | RM195.34 Million |
|
Vow ASA
OL:VOW
|
Norway | Nkr849.80 Million |
|
EML Payments Ltd
F:A8Y1
|
Germany | €2.54 Billion |
|
Hindustan Media Ventures Limited
NSE:HMVL
|
India | Rs8.78 Billion |
|
Unitronics
TA:UNIT
|
Israel | ILA58.52 Million |
|
Africa Energy Corp
V:AFE
|
Canada | CA$316.00K |
Liability Composition Analysis (2018–2025)
This chart breaks down Outset Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Outset Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Outset Medical Inc (2018–2025)
The table below shows the annual total liabilities of Outset Medical Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $137.54 Million | -44.76% |
| 2024-12-31 | $248.98 Million | +30.41% |
| 2023-12-31 | $190.91 Million | +23.87% |
| 2022-12-31 | $154.12 Million | +72.43% |
| 2021-12-31 | $89.38 Million | +18.83% |
| 2020-12-31 | $75.22 Million | -83.67% |
| 2019-12-31 | $460.55 Million | +4.89% |
| 2018-12-31 | $439.08 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more